Pancreatic Cancer: Recent Advances and Future Challenges

Dear Colleagues,

As Guest Editors, we are pleased to announce the launch of a new Special Issue entitled “Pancreatic Cancer: Recent Advances and Future Challenges” to be published in the Journal of Clinical Medicine (JCM, Impact Factor 4.964, https://www.mdpi.com/journal/jcm).

Pancreatic cancer is a lethal disease with the poorest survival rate of any solid malignancy. Alarmingly, incidence and mortality rates for pancreatic cancer have continued to rise during the past two decades, in stark contrast with other common cancer types. However, remarkable strides have been made in the molecular understanding of pancreatic cancer, clinical trials using novel multi-drug chemotherapies have shown promising survival outcomes, and pancreatic surgery is less invasive and saver than ever before. Due to these advances in multi-modality care, treatment indications and options have expanded even for patients with locally advanced, oligometastatic or recurrent disease. On the other hand, these improvements add to the complexity of providing multi-disciplinary treatment for pancreatic cancer patients.

This multi-modality care opens the door to new strategies and innovations related to, for instance, artificial intelligence (AI), neoadjuvant and adjuvant therapies, robotic surgery, radiation therapy and immune therapy. To work towards truly personalized care for pancreatic cancer, we need improved tools for patient and treatment selection, superior biomarkers and radiomics to measure treatment response and novel therapies that target tumor-specific genetic vulnerabilities. This Special Issue hopes to address these current advances and future challenges in the field of pancreatic cancer research to help achieve profoundly improved outcomes for patients.

As such, we cordially invite you to submit your original or review article on clinical or translational research to this Special Issue of JCM on “Pancreatic Cancer: Recent Advances and Future Challenges”.

Dr. Vincent P. Groot
Dr. Lois A. Daamen
Prof. Dr. Izaäk Quintus Molenaar
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.